Follow
Simon Portsmouth
Simon Portsmouth
Shionogi Inc
Verified email at shionogi.com
Title
Cited by
Cited by
Year
Baloxavir marboxil for uncomplicated influenza in adults and adolescents
FG Hayden, N Sugaya, N Hirotsu, N Lee, MD de Jong, AC Hurt, T Ishida, ...
New England Journal of Medicine 379 (10), 913-923, 2018
8232018
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5722008
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a …
M Bassetti, R Echols, Y Matsunaga, M Ariyasu, Y Doi, R Ferrer, TP Lodise, ...
The Lancet infectious diseases 21 (2), 226-240, 2021
4872021
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non …
S Portsmouth, D van Veenhuyzen, R Echols, M Machida, JCA Ferreira, ...
The Lancet Infectious Diseases 18 (12), 1319-1328, 2018
3472018
Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions
P Mwaba, J Mwansa, C Chintu, J Pobee, M Scarborough, S Portsmouth, ...
Postgraduate medical journal 77 (914), 769-773, 2001
2372001
An open-label study of tenofovir in HIV-1 and hepatitis B virus co-infected individuals
M Nelson, S Portsmouth, J Stebbing, M Atkins, A Barr, G Matthews, ...
Aids 17 (1), F7-F10, 2003
2332003
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma
S Portsmouth, J Stebbing, J Gill, S Mandalia, M Bower, M Nelson, ...
Aids 17 (11), F17-F22, 2003
1952003
Treatment-emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza
T Uehara, FG Hayden, K Kawaguchi, S Omoto, AC Hurt, MD De Jong, ...
The Journal of infectious diseases 221 (3), 346-355, 2020
1712020
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
MG Ison, S Portsmouth, Y Yoshida, T Shishido, M Mitchener, K Tsuchiya, ...
The Lancet Infectious Diseases 20 (10), 1204-1214, 2020
1702020
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial
SMART Study Group*
Annals of internal medicine 149 (5), 289-299, 2008
1672008
Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc
LC Swenson, T Mo, WWY Dong, X Zhong, CK Woods, A Thielen, ...
Clinical infectious diseases 53 (7), 732-742, 2011
1132011
Better maintained adherence on switching from twice‐daily to once‐daily therapy for HIV: a 24‐week randomized trial of treatment simplification using stavudine prolonged …
SD Portsmouth, J Osorio, K McCormick, BG Gazzard, GJ Moyle
HIV medicine 6 (3), 185-190, 2005
922005
Paclitaxel for anthracycline-resistant AIDS-related Kaposi’s sarcoma: clinical and angiogenic correlations
J Stebbing, A Wildfire, S Portsmouth, T Powles, C Thirlwell, P Hewitt, ...
Annals of Oncology 14 (11), 1660-1666, 2003
812003
A questionnaire survey of stress and bullying in doctors undertaking research
J Stebbing, S Mandalia, S Portsmouth, P Leonard, J Crane, M Bower, ...
Postgraduate Medical Journal 80 (940), 93-96, 2004
702004
Etiology and natural history of neutropenia in human immunodeficiency virus disease: a prospective study
DAJ Moore, T Benepal, S Portsmouth, J Gill, BG Gazzard
Clinical infectious diseases 32 (3), 469-475, 2001
642001
The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1–infected “true” long-term nonprogressors
J Stebbing, B Gazzard, L Kim, S Portsmouth, A Wildfire, I Teo, M Nelson, ...
Blood, The Journal of the American Society of Hematology 101 (10), 4000-4004, 2003
632003
LB16. Phase 3 trial of baloxavir marboxil in high-risk influenza patients (CAPSTONE-2 Study)
MG Ison, S Portsmouth, Y Yoshida, T Shishido, F Hayden, T Uehara
Open Forum Infectious Diseases 5 (Suppl 1), S764, 2018
582018
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor
J Stebbing, B Gazzard, S Portsmouth, F Gotch, L Kim, M Bower, ...
Blood 102 (5), 1806-1814, 2003
572003
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial
RA McGovern, A Thielen, S Portsmouth, T Mo, W Dong, CK Woods, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 61 (3), 279-286, 2012
562012
Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study
A Mills, D Mildvan, D Podzamczer, G Fätkenheuer, M Leal, S Than, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (2), 164-170, 2013
532013
The system can't perform the operation now. Try again later.
Articles 1–20